RPSA

Small ribosomal subunit protein uS2 · P08865 · RPSA on Sugi Atlas →

3,701 patent compounds predicted against RPSA, 1,950 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL5500526 SCHEMBL5500526 0.41 4/20
SCHEMBL5500532 SCHEMBL5500532 0.41 4/20
SCHEMBL5503310 SCHEMBL5503310 0.41 4/20
SCHEMBL11844361 SCHEMBL11844361 0.35 4/20
SCHEMBL2000440 SCHEMBL2000440 0.39 3/20
SCHEMBL8219903 SCHEMBL8219903 0.36 3/20
SCHEMBL11627320 SCHEMBL11627320 0.34 3/20
SCHEMBL10271044 SCHEMBL10271044 0.55 2/20
SCHEMBL6394396 SCHEMBL6394396 0.47 2/20
N-Methylpiperidine N-Methylpiperidine (SCHEMBL11205373) 0.42 2/20
Bicarbonate Bicarbonate (SCHEMBL9058396) 0.42 2/20
SCHEMBL4960293 SCHEMBL4960293 0.41 2/20
SCHEMBL4961968 SCHEMBL4961968 0.40 2/20
SCHEMBL6686992 SCHEMBL6686992 0.40 2/20
SCHEMBL9429122 SCHEMBL9429122 0.38 2/20
Chloramphenicol Chloramphenicol (SCHEMBL10796001) 1.00 1/20
Geneticin Geneticin (SCHEMBL15596) 0.93 1/20
Geneticin Geneticin (SCHEMBL5006573) 0.93 1/20
Geneticin Geneticin (SCHEMBL9920496) 0.93 1/20
Chloramphenicol Chloramphenicol (SCHEMBL16111) 0.90 1/20

Clinical trials — most relevant to RPSA by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Sirolimus Treatment for Refractory PRCA PHASE4COMPLETED
Tacrolimus Treatment for Refractory PRCA PHASE4UNKNOWN
Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA PHASE4COMPLETED
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer PHASE1/PHASE2COMPLETED
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia PHASE1RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS) nanRECRUITING
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
SWE to Detect Enthesitis in PsA: Relationship With SIRT2 Expression and Disease Activity nanNOT_YET_RECRUITING
Natural History and Genetic Studies of Usher Syndrome nanCOMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Trichomonas Vaginalis Genotyping in Upper Egypt nanUNKNOWN
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Role of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma nanRECRUITING
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Shwachman Diamond Syndrome Registry and Study nanRECRUITING
Genetic Analysis of Gray Platelet Syndrome nanCOMPLETED
Advancing Neurogenetic Diagnoses Through Long-Read Sequencing nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a RPSA binder may also engage these)

ProteinNameSimilarity
G1TLT8 1.000 G1TLT8 →
P14206 1.000 P14206 →
Q2L9X0 1.000 Q2L9X0 →
B5FXT6 1.000 B5FXT6 →
P26452 1.000 P26452 →
P38982 1.000 P38982 →
Q6P8D1 1.000 Q6P8D1 →
Q4GWZ2 1.000 Q4GWZ2 →
P50890 1.000 P50890 →
A0A8I5KQE6 1.000 A0A8I5KQE6 →
A6YRY8 1.000 A6YRY8 →
P38983 1.000 P38983 →
Q4QY71 1.000 Q4QY71 →
Q3ZM03 1.000 Q3ZM03 →
B5DGB6 1.000 B5DGB6 →
P38981 1.000 P38981 →
C0NKW7 1.000 C0NKW7 →
B2B1Z3 1.000 B2B1Z3 →
Q5UAP4 1.000 Q5UAP4 →
Q2GV75 1.000 Q2GV75 →
A7RKS5 1.000 A7RKS5 →
Q803F6 1.000 Q803F6 →
Q90YS4 1.000 Q90YS4 →
A6NA00 1.000 A6NA00 →
Q8H173 1.000 Q8H173 →
B6K1S2 1.000 B6K1S2 →
C5PA09 1.000 C5PA09 →
Q4WYK1 1.000 Q4WYK1 →
Q5B8F8 1.000 Q5B8F8 →
Q0PXX8 1.000 Q0PXX8 →